Abstract Background Alzheimer Disease (AD) is a complex pathology, in which several
biochemical pathways could be involved. Therefore, the development of clinical studies …

Alzheimer's Disease (AD) is a neurodegenerative disorder characterized by the
accumulation of amyloid plaques and hyperphosphorylated tau in the brain. Currently …

Cholinesterase (ChE) enzymes have been identified as diagnostic markers for Alzheimer
disease (AD). Substrate-based probes have been synthesised to detect ChEs but they have …

Alzheimer's disease (AD), one of the most widespread neurodegenerative disorder, is a fatal
global burden for the elder population. Although many efforts have been made, the search of …

An increasing number of genes associated with Alzheimer's disease (AD genes) have been
reported. However, there is a lack of an overview of the genetic relationship between AD …

Alzheimer's disease (AD) is a critical health issue worldwide that has a negative impact on
patients' quality of life, as well as on caregivers, society, and the environment. Positron …

Alzheimer's disease (AD), a neurodegenerative disease with no cure, affects millions of
people worldwide and has become one of the biggest healthcare challenges. Some …

Recent advancements in AI, big data analytics, and magnetic resonance imaging (MRI)
have revolutionized the study of brain diseases such as Alzheimer's Disease (AD). However …

INTRODUCTION The secreted phosphoprotein 1 (SPP1) gene expressed by CD11c+ cells
is known to be associated with microglia activation and neuroinflammatory diseases. As …

Alzheimer's disease (AD) is a chronic, insidious, and progressive neuro‐degenerative
disease that remains a clinical challenge for society. The fully approved drug lecanemab …